We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Prevalence of Parvovirus B19 Infection Among Patients With Human Immunodeficiency Virus Infection in Barcelona, Spain

Eugenia Negredo, MD; Pere Domingo, MD; Nuria Rabella, MD; Joaquín López-Contreras, MD; Angels Fontanet, RN; Inmaculada Orellana, RN
Arch Intern Med. 1998;158(6):680-681. doi:.
Text Size: A A A
Published online


Anemia is one of the most common hematologic abnormalities in patients with acquired immunodeficiency syndrome, affecting as many as 80% of patients. Opportunistic infections, myelosuppressive drugs (antiretroviral medications, ganciclovir, or cytotoxic chemotherapy), neoplasms, or immunologic changes induced by human immunodeficiency virus (HIV) may contribute to the cause of anemia. Parvovirus B19 (PV B19) is known to cause a pure red cell aplasia through a lysis of erythroid progenitor cells.1 Thus, PV B19 infection is another potential mechanism of anemia in HIV-infected patients. However, there are some controversial points related to PV B19 infection in this population: First, its prevalence in HIV-infected patients is variable and ranges from 10% to 60%24; second, the prevalence of PV B19 infection that causes anemia in HIV-infected individuals26; and third, the ideal diagnostic method for treating PV B19 infection in patients with acquired immunodeficiency syndrome. It has been suggested that serological testing may not be a sensitive diagnostic method because of the poor immunologic response in immunocompromised patients.2,4,7 Thus, the detection of PV B19 nucleic acids using DNA hybridization or polymerase chain reaction has been proposed as the standard diagnostic method.2,4,6,7

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections